Skip to main content

Ryan Richardson

Equibles does not estimate personal net worth.

Get an email with a short summary when Autolus Therapeutics plc publishes a filing, an earnings call transcript or a press release.

Get AUTL alerts

About Ryan Richardson

Ryan Richardson is recorded as Board Member at Autolus Therapeutics plc (AUTL) since December 1, 2025. Autolus Therapeutics plc reported in an 8-K filed December 2, 2025 that Ryan Richardson was appointed Class I director, effective December 1, 2025. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Michael W. Bonney (Chairman and Board Member), Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer) and 3 others.

“On December 1, 2025, Autolus Therapeutics plc (the "Company") announced that its board of directors (the "Board"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ryan Richardson to serve as a Class I director of the Company, effective December 1, 2025 and continuing until the Company's 2028 annual general meeting of shareholders, or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.”
Autolus Therapeutics plc Form 8-K, filed December 2, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Autolus Therapeutics plc

Recent activity